FF:11411-118E7: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 69: | Line 69: | ||
|sample_ethnicity=C | |sample_ethnicity=C | ||
|sample_experimental_condition= | |sample_experimental_condition= | ||
|sample_gostat=GO:0044464;cell part;0!GO:0005622;intracellular;0!GO:0044424;intracellular part;9.14724080568305e-220!GO:0005737;cytoplasm;7.1853857043221e-174!GO:0043226;organelle;4.38263783866283e-145!GO:0043229;intracellular organelle;1.3374397874571e-144!GO:0043231;intracellular membrane-bound organelle;6.19156386690128e-144!GO:0043227;membrane-bound organelle;1.29962983043627e-143!GO:0044444;cytoplasmic part;2.3246979477982e-124!GO:0044422;organelle part;6.14295531062426e-101!GO:0044446;intracellular organelle part;1.22060575150323e-99!GO:0005515;protein binding;2.71359377869841e-78!GO:0032991;macromolecular complex;2.11241381221148e-68!GO:0044238;primary metabolic process;2.79671870074412e-67!GO:0044237;cellular metabolic process;1.57578050715145e-66!GO:0043170;macromolecule metabolic process;1.02252972792585e-64!GO:0030529;ribonucleoprotein complex;3.72849441892563e-63!GO:0005739;mitochondrion;1.20319332903515e-51!GO:0043233;organelle lumen;1.21055941173137e-51!GO:0031974;membrane-enclosed lumen;1.21055941173137e-51!GO:0003723;RNA binding;2.92200427809987e-47!GO:0031090;organelle membrane;7.52204569093973e-46!GO:0044428;nuclear part;2.15416130323344e-44!GO:0005634;nucleus;4.4773757853102e-44!GO:0019538;protein metabolic process;1.09529288773418e-43!GO:0016043;cellular component organization and biogenesis;1.11673124352986e-40!GO:0005840;ribosome;1.61321657975983e-39!GO:0015031;protein transport;6.03239479727928e-39!GO:0006412;translation;9.22169432171989e-39!GO:0044260;cellular macromolecule metabolic process;1.48415845744926e-38!GO:0033036;macromolecule localization;3.2728861584388e-37!GO:0044267;cellular protein metabolic process;5.74091597860778e-37!GO:0045184;establishment of protein localization;3.20317529604429e-36!GO:0008104;protein localization;2.18021446168226e-35!GO:0003735;structural constituent of ribosome;4.5890203375431e-35!GO:0044429;mitochondrial part;1.70790708666587e-34!GO:0009059;macromolecule biosynthetic process;7.50502399229109e-34!GO:0043234;protein complex;1.00348424759825e-33!GO:0005829;cytosol;1.29178514731698e-33!GO:0009058;biosynthetic process;1.46977305504819e-32!GO:0033279;ribosomal subunit;2.71997195432485e-32!GO:0006396;RNA processing;1.42034907838136e-31!GO:0043283;biopolymer metabolic process;2.95856751434736e-30!GO:0044249;cellular biosynthetic process;4.35700614206121e-30!GO:0046907;intracellular transport;3.45069405021059e-29!GO:0031967;organelle envelope;8.12626908380783e-29!GO:0010467;gene expression;1.02620145089124e-28!GO:0031975;envelope;1.7060977346545e-28!GO:0031981;nuclear lumen;3.42127841410511e-28!GO:0016071;mRNA metabolic process;2.34523717114367e-27!GO:0006886;intracellular protein transport;5.37780353859199e-27!GO:0008380;RNA splicing;2.21367284591464e-25!GO:0005830;cytosolic ribosome (sensu Eukaryota);9.41449670523629e-25!GO:0065003;macromolecular complex assembly;2.59928772211814e-24!GO:0005740;mitochondrial envelope;5.55298212406014e-24!GO:0005783;endoplasmic reticulum;8.41212865977807e-24!GO:0006139;nucleobase, nucleoside, nucleotide and nucleic acid metabolic process;1.98747946600275e-23!GO:0006397;mRNA processing;3.10580881034181e-23!GO:0031966;mitochondrial membrane;6.30053149986096e-23!GO:0022607;cellular component assembly;4.28470812492578e-22!GO:0019866;organelle inner membrane;2.29999271350189e-21!GO:0005743;mitochondrial inner membrane;1.26016156250212e-20!GO:0022613;ribonucleoprotein complex biogenesis and assembly;1.14271959277987e-19!GO:0006119;oxidative phosphorylation;3.67956521548482e-19!GO:0005794;Golgi apparatus;8.26231237525753e-19!GO:0006996;organelle organization and biogenesis;1.26943208771401e-18!GO:0044445;cytosolic part;1.52339543772226e-18!GO:0005681;spliceosome;2.34414544405649e-18!GO:0012505;endomembrane system;7.02036051573423e-18!GO:0008134;transcription factor binding;7.4834097847144e-18!GO:0051649;establishment of cellular localization;7.4834097847144e-18!GO:0005654;nucleoplasm;1.12331791574051e-17!GO:0051641;cellular localization;1.30421885919657e-17!GO:0006457;protein folding;2.25596620430774e-17!GO:0044432;endoplasmic reticulum part;2.80697575950181e-17!GO:0048770;pigment granule;3.27381349173212e-17!GO:0042470;melanosome;3.27381349173212e-17!GO:0044455;mitochondrial membrane part;3.40012459445418e-17!GO:0043228;non-membrane-bound organelle;6.43290061593291e-17!GO:0043232;intracellular non-membrane-bound organelle;6.43290061593291e-17!GO:0015934;large ribosomal subunit;1.05658603531624e-16!GO:0015935;small ribosomal subunit;1.47989275792413e-16!GO:0005746;mitochondrial respiratory chain;1.45577004770757e-15!GO:0044451;nucleoplasm part;6.82352399806155e-15!GO:0006605;protein targeting;2.05749912528112e-14!GO:0044265;cellular macromolecule catabolic process;2.59355182066409e-14!GO:0043285;biopolymer catabolic process;2.78541788770847e-14!GO:0016655;oxidoreductase activity, acting on NADH or NADPH, quinone or similar compound as acceptor;2.91496951261178e-14!GO:0009057;macromolecule catabolic process;3.28427395760528e-14!GO:0016874;ligase activity;4.56193429022402e-14!GO:0000502;proteasome complex (sensu Eukaryota);4.83257708850321e-14!GO:0048523;negative regulation of cellular process;7.5602212899711e-14!GO:0048193;Golgi vesicle transport;8.34339996825544e-14!GO:0050136;NADH dehydrogenase (quinone) activity;1.32603505230113e-13!GO:0003954;NADH dehydrogenase activity;1.32603505230113e-13!GO:0008137;NADH dehydrogenase (ubiquinone) activity;1.32603505230113e-13!GO:0006512;ubiquitin cycle;2.90395125461769e-13!GO:0022618;protein-RNA complex assembly;3.46384042811134e-13!GO:0031980;mitochondrial lumen;3.46384042811134e-13!GO:0005759;mitochondrial matrix;3.46384042811134e-13!GO:0016192;vesicle-mediated transport;3.46623096392009e-13!GO:0005843;cytosolic small ribosomal subunit (sensu Eukaryota);5.46241918980651e-13!GO:0016462;pyrophosphatase activity;6.75941510790281e-13!GO:0012501;programmed cell death;7.24583506847207e-13!GO:0006259;DNA metabolic process;7.84463207785887e-13!GO:0016818;hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides;1.16355602976618e-12!GO:0016817;hydrolase activity, acting on acid anhydrides;1.59574788479082e-12!GO:0006915;apoptosis;1.73862829446464e-12!GO:0005842;cytosolic large ribosomal subunit (sensu Eukaryota);1.91354631374851e-12!GO:0008135;translation factor activity, nucleic acid binding;2.4210882285394e-12!GO:0016070;RNA metabolic process;2.53731859605396e-12!GO:0051186;cofactor metabolic process;2.53731859605396e-12!GO:0051082;unfolded protein binding;2.85218162144701e-12!GO:0030163;protein catabolic process;2.94134739916915e-12!GO:0017111;nucleoside-triphosphatase activity;3.22553949601699e-12!GO:0005793;ER-Golgi intermediate compartment;3.22553949601699e-12!GO:0003676;nucleic acid binding;3.35128648603863e-12!GO:0000166;nucleotide binding;6.9511129178545e-12!GO:0048519;negative regulation of biological process;8.15899249581469e-12!GO:0030964;NADH dehydrogenase complex (quinone);8.64512835736525e-12!GO:0045271;respiratory chain complex I;8.64512835736525e-12!GO:0005747;mitochondrial respiratory chain complex I;8.64512835736525e-12!GO:0051603;proteolysis involved in cellular protein catabolic process;8.81970350531717e-12!GO:0044248;cellular catabolic process;9.53100508700763e-12!GO:0042775;organelle ATP synthesis coupled electron transport;1.26725899658516e-11!GO:0042773;ATP synthesis coupled electron transport;1.26725899658516e-11!GO:0016651;oxidoreductase activity, acting on NADH or NADPH;1.43407262934649e-11!GO:0008219;cell death;1.59588486433217e-11!GO:0016265;death;1.59588486433217e-11!GO:0019941;modification-dependent protein catabolic process;1.60157650890741e-11!GO:0043632;modification-dependent macromolecule catabolic process;1.60157650890741e-11!GO:0006511;ubiquitin-dependent protein catabolic process;1.69875021366643e-11!GO:0044257;cellular protein catabolic process;1.80934385087826e-11!GO:0006120;mitochondrial electron transport, NADH to ubiquinone;2.79509350993848e-11!GO:0042175;nuclear envelope-endoplasmic reticulum network;5.17054865407483e-11!GO:0005730;nucleolus;5.26512519742686e-11!GO:0005761;mitochondrial ribosome;7.30596505853322e-11!GO:0000313;organellar ribosome;7.30596505853322e-11!GO:0005789;endoplasmic reticulum membrane;9.28703181930631e-11!GO:0009055;electron carrier activity;1.22837179435167e-10!GO:0003712;transcription cofactor activity;1.26435323698904e-10!GO:0005788;endoplasmic reticulum lumen;4.08205563974319e-10!GO:0006732;coenzyme metabolic process;4.6139725118237e-10!GO:0003743;translation initiation factor activity;8.7174930253995e-10!GO:0006366;transcription from RNA polymerase II promoter;1.02680172754693e-09!GO:0000398;nuclear mRNA splicing, via spliceosome;1.15644876619506e-09!GO:0000375;RNA splicing, via transesterification reactions;1.15644876619506e-09!GO:0000377;RNA splicing, via transesterification reactions with bulged adenosine as nucleophile;1.15644876619506e-09!GO:0006913;nucleocytoplasmic transport;1.40413791194477e-09!GO:0043412;biopolymer modification;2.1522968496528e-09!GO:0017038;protein import;2.29402649434841e-09!GO:0051169;nuclear transport;2.58579221155827e-09!GO:0050794;regulation of cellular process;3.25668322807719e-09!GO:0008361;regulation of cell size;8.45837522287024e-09!GO:0016049;cell growth;9.00547632732883e-09!GO:0006464;protein modification process;1.01007471313913e-08!GO:0007049;cell cycle;1.25573325585931e-08!GO:0005581;collagen;1.25573325585931e-08!GO:0042981;regulation of apoptosis;1.32751446275619e-08!GO:0043067;regulation of programmed cell death;1.32866388924563e-08!GO:0044431;Golgi apparatus part;1.42890639838626e-08!GO:0008639;small protein conjugating enzyme activity;1.53428769125122e-08!GO:0043069;negative regulation of programmed cell death;1.5660381829025e-08!GO:0006413;translational initiation;2.17275950444015e-08!GO:0004842;ubiquitin-protein ligase activity;2.62393198185253e-08!GO:0031324;negative regulation of cellular metabolic process;2.66030984194625e-08!GO:0043066;negative regulation of apoptosis;3.01611783169274e-08!GO:0032553;ribonucleotide binding;3.04533118277047e-08!GO:0032555;purine ribonucleotide binding;3.04533118277047e-08!GO:0030120;vesicle coat;3.26244463824641e-08!GO:0030662;coated vesicle membrane;3.26244463824641e-08!GO:0006888;ER to Golgi vesicle-mediated transport;3.38246055458626e-08!GO:0005768;endosome;3.43319096383413e-08!GO:0009056;catabolic process;3.54956392578726e-08!GO:0046961;hydrogen ion transporting ATPase activity, rotational mechanism;3.89997819275229e-08!GO:0019787;small conjugating protein ligase activity;3.92738206223297e-08!GO:0017076;purine nucleotide binding;4.76526746420376e-08!GO:0006446;regulation of translational initiation;4.9208400665507e-08!GO:0006461;protein complex assembly;5.62503265517875e-08!GO:0016879;ligase activity, forming carbon-nitrogen bonds;6.3335489378967e-08!GO:0016604;nuclear body;6.35441714683119e-08!GO:0008565;protein transporter activity;7.2787439842737e-08!GO:0016564;transcription repressor activity;7.32864923340753e-08!GO:0006163;purine nucleotide metabolic process;7.41914422346042e-08!GO:0001558;regulation of cell growth;8.75593041180689e-08!GO:0003924;GTPase activity;9.08141151726013e-08!GO:0009259;ribonucleotide metabolic process;9.94416881292054e-08!GO:0046933;hydrogen ion transporting ATP synthase activity, rotational mechanism;1.11366331078004e-07!GO:0009150;purine ribonucleotide metabolic process;1.12523488508204e-07!GO:0006916;anti-apoptosis;1.26814970255432e-07!GO:0043123;positive regulation of I-kappaB kinase/NF-kappaB cascade;2.20872984904078e-07!GO:0003714;transcription corepressor activity;2.34620075158828e-07!GO:0006164;purine nucleotide biosynthetic process;2.39396100476253e-07!GO:0044262;cellular carbohydrate metabolic process;2.45549117025479e-07!GO:0051246;regulation of protein metabolic process;2.47328195574373e-07!GO:0051726;regulation of cell cycle;2.62893199911571e-07!GO:0042254;ribosome biogenesis and assembly;2.71419592860713e-07!GO:0016881;acid-amino acid ligase activity;2.98804255954538e-07!GO:0000074;regulation of progression through cell cycle;3.00924066812278e-07!GO:0016491;oxidoreductase activity;3.16526318411602e-07!GO:0043687;post-translational protein modification;3.3391258861137e-07!GO:0009152;purine ribonucleotide biosynthetic process;3.48148492040071e-07!GO:0043122;regulation of I-kappaB kinase/NF-kappaB cascade;4.65263413365214e-07!GO:0009892;negative regulation of metabolic process;4.90578133546997e-07!GO:0005773;vacuole;4.9504380669181e-07!GO:0048475;coated membrane;5.16406134152681e-07!GO:0030117;membrane coat;5.16406134152681e-07!GO:0015986;ATP synthesis coupled proton transport;5.33617554487414e-07!GO:0015985;energy coupled proton transport, down electrochemical gradient;5.33617554487414e-07!GO:0045333;cellular respiration;5.37407665227213e-07!GO:0009060;aerobic respiration;5.57518673092563e-07!GO:0009260;ribonucleotide biosynthetic process;6.63244489352855e-07!GO:0044420;extracellular matrix part;7.57671139653636e-07!GO:0006325;establishment and/or maintenance of chromatin architecture;8.33247647926847e-07!GO:0050789;regulation of biological process;8.79024896061603e-07!GO:0031965;nuclear membrane;9.74112135300154e-07!GO:0051170;nuclear import;9.84294581218967e-07!GO:0006606;protein import into nucleus;1.03258307862392e-06!GO:0009205;purine ribonucleoside triphosphate metabolic process;1.09766183343169e-06!GO:0009144;purine nucleoside triphosphate metabolic process;1.09766183343169e-06!GO:0009199;ribonucleoside triphosphate metabolic process;1.29809754550943e-06!GO:0005839;proteasome core complex (sensu Eukaryota);1.30598448166131e-06!GO:0007249;I-kappaB kinase/NF-kappaB cascade;1.43592044172868e-06!GO:0000139;Golgi membrane;1.43592044172868e-06!GO:0009206;purine ribonucleoside triphosphate biosynthetic process;1.43592044172868e-06!GO:0009145;purine nucleoside triphosphate biosynthetic process;1.43592044172868e-06!GO:0009142;nucleoside triphosphate biosynthetic process;1.75202156923481e-06!GO:0009201;ribonucleoside triphosphate biosynthetic process;1.75202156923481e-06!GO:0016607;nuclear speck;1.75464465976088e-06!GO:0045786;negative regulation of progression through cell cycle;1.80086008770815e-06!GO:0009141;nucleoside triphosphate metabolic process;1.81943740031528e-06!GO:0022402;cell cycle process;1.85037066929736e-06!GO:0006323;DNA packaging;2.47937702878061e-06!GO:0015078;hydrogen ion transmembrane transporter activity;2.5376172902911e-06!GO:0005635;nuclear envelope;2.98959825753424e-06!GO:0051789;response to protein stimulus;3.2309641598579e-06!GO:0006986;response to unfolded protein;3.2309641598579e-06!GO:0030532;small nuclear ribonucleoprotein complex;3.876828223559e-06!GO:0019829;cation-transporting ATPase activity;4.30985457947759e-06!GO:0051188;cofactor biosynthetic process;4.50899429635875e-06!GO:0030036;actin cytoskeleton organization and biogenesis;4.93236040983802e-06!GO:0044440;endosomal part;5.23462552248712e-06!GO:0010008;endosome membrane;5.23462552248712e-06!GO:0016876;ligase activity, forming aminoacyl-tRNA and related compounds;5.39175952609308e-06!GO:0004812;aminoacyl-tRNA ligase activity;5.39175952609308e-06!GO:0016875;ligase activity, forming carbon-oxygen bonds;5.39175952609308e-06!GO:0046034;ATP metabolic process;5.54601889714992e-06!GO:0006974;response to DNA damage stimulus;5.8352461705118e-06!GO:0055086;nucleobase, nucleoside and nucleotide metabolic process;5.88673366458223e-06!GO:0006754;ATP biosynthetic process;5.95422889105086e-06!GO:0006753;nucleoside phosphate metabolic process;5.95422889105086e-06!GO:0000323;lytic vacuole;6.14223342132542e-06!GO:0005764;lysosome;6.14223342132542e-06!GO:0016023;cytoplasmic membrane-bound vesicle;6.28398656283503e-06!GO:0004298;threonine endopeptidase activity;6.36145144619967e-06!GO:0005583;fibrillar collagen;6.37854830933027e-06!GO:0016469;proton-transporting two-sector ATPase complex;6.85107729374156e-06!GO:0051187;cofactor catabolic process;6.98025984672493e-06!GO:0040008;regulation of growth;6.99916683606408e-06!GO:0016481;negative regulation of transcription;7.22588268563282e-06!GO:0045934;negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process;7.62819113940133e-06!GO:0031988;membrane-bound vesicle;7.93155748247238e-06!GO:0031252;leading edge;8.19840955146641e-06!GO:0043038;amino acid activation;8.68228595419195e-06!GO:0006418;tRNA aminoacylation for protein translation;8.68228595419195e-06!GO:0043039;tRNA aminoacylation;8.68228595419195e-06!GO:0005798;Golgi-associated vesicle;8.80469016357256e-06!GO:0006099;tricarboxylic acid cycle;9.08940172217888e-06!GO:0046356;acetyl-CoA catabolic process;9.08940172217888e-06!GO:0006399;tRNA metabolic process;9.08940172217888e-06!GO:0044453;nuclear membrane part;9.81570565471263e-06!GO:0007005;mitochondrion organization and biogenesis;1.07955225681115e-05!GO:0065002;intracellular protein transport across a membrane;1.0979668004854e-05!GO:0065004;protein-DNA complex assembly;1.19000633817703e-05!GO:0005525;GTP binding;1.26204786057014e-05!GO:0031982;vesicle;1.3618439077524e-05!GO:0048522;positive regulation of cellular process;1.51967484289288e-05!GO:0009109;coenzyme catabolic process;1.61117658629435e-05!GO:0005524;ATP binding;1.62562427053439e-05!GO:0031410;cytoplasmic vesicle;1.78591498640628e-05!GO:0045259;proton-transporting ATP synthase complex;2.28250365127282e-05!GO:0008654;phospholipid biosynthetic process;2.39764112928518e-05!GO:0032559;adenyl ribonucleotide binding;2.52616807224156e-05!GO:0006084;acetyl-CoA metabolic process;2.59299933265815e-05!GO:0006091;generation of precursor metabolites and energy;3.01578857495272e-05!GO:0007243;protein kinase cascade;3.36497343237063e-05!GO:0006613;cotranslational protein targeting to membrane;3.43617989218303e-05!GO:0051276;chromosome organization and biogenesis;3.49757941557825e-05!GO:0030554;adenyl nucleotide binding;4.27654172838894e-05!GO:0006752;group transfer coenzyme metabolic process;4.27654172838894e-05!GO:0003697;single-stranded DNA binding;4.29551909845639e-05!GO:0005770;late endosome;4.40226355814522e-05!GO:0030133;transport vesicle;4.48480749205419e-05!GO:0030867;rough endoplasmic reticulum membrane;4.54778527117173e-05!GO:0016853;isomerase activity;4.73664545877226e-05!GO:0005667;transcription factor complex;4.73664545877226e-05!GO:0009719;response to endogenous stimulus;4.75698558999157e-05!GO:0019843;rRNA binding;4.85314115229059e-05!GO:0006793;phosphorus metabolic process;4.96390204524307e-05!GO:0006796;phosphate metabolic process;4.96390204524307e-05!GO:0005643;nuclear pore;4.97712907812132e-05!GO:0006333;chromatin assembly or disassembly;5.02204768716048e-05!GO:0006364;rRNA processing;5.5349433401542e-05!GO:0009117;nucleotide metabolic process;5.96066605627275e-05!GO:0030029;actin filament-based process;5.99441507551922e-05!GO:0042623;ATPase activity, coupled;6.50729607650499e-05!GO:0009108;coenzyme biosynthetic process;7.09976215139562e-05!GO:0043566;structure-specific DNA binding;7.30422719824694e-05!GO:0004386;helicase activity;7.31545841335341e-05!GO:0033116;ER-Golgi intermediate compartment membrane;7.81552783879875e-05!GO:0016563;transcription activator activity;7.98567390605033e-05!GO:0016072;rRNA metabolic process;8.58505088138281e-05!GO:0031202;RNA splicing factor activity, transesterification mechanism;8.58986612914319e-05!GO:0045454;cell redox homeostasis;8.59240115146227e-05!GO:0008026;ATP-dependent helicase activity;8.84436494769834e-05!GO:0016887;ATPase activity;8.88702291256754e-05!GO:0016591;DNA-directed RNA polymerase II, holoenzyme;9.34002758139324e-05!GO:0015980;energy derivation by oxidation of organic compounds;9.74994444083455e-05!GO:0000245;spliceosome assembly;0.000103914164473284!GO:0000151;ubiquitin ligase complex;0.000109698054995435!GO:0005762;mitochondrial large ribosomal subunit;0.000113566498756257!GO:0000315;organellar large ribosomal subunit;0.000113566498756257!GO:0006357;regulation of transcription from RNA polymerase II promoter;0.000114907445422045!GO:0032561;guanyl ribonucleotide binding;0.000125512657147786!GO:0019001;guanyl nucleotide binding;0.000125512657147786!GO:0005769;early endosome;0.000132435203580613!GO:0015077;monovalent inorganic cation transmembrane transporter activity;0.000138523139048599!GO:0000278;mitotic cell cycle;0.000148893595529156!GO:0032446;protein modification by small protein conjugation;0.000152815879109959!GO:0003755;peptidyl-prolyl cis-trans isomerase activity;0.000164933793171852!GO:0005905;coated pit;0.000166866608436022!GO:0016859;cis-trans isomerase activity;0.000178694617392269!GO:0016567;protein ubiquitination;0.000182142756205857!GO:0006281;DNA repair;0.000182990620124724!GO:0019867;outer membrane;0.000192651032876135!GO:0003713;transcription coactivator activity;0.000193568282877266!GO:0016568;chromatin modification;0.000208774242470101!GO:0051427;hormone receptor binding;0.000224767899373078!GO:0000785;chromatin;0.000237169266059911!GO:0005741;mitochondrial outer membrane;0.000306432374606755!GO:0016706;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors;0.000335710885447372!GO:0019899;enzyme binding;0.000337388748897783!GO:0008250;oligosaccharyl transferase complex;0.000337388748897783!GO:0031968;organelle outer membrane;0.000348980253244548!GO:0016310;phosphorylation;0.000349011554159379!GO:0016740;transferase activity;0.000376221942602009!GO:0007264;small GTPase mediated signal transduction;0.000409662526154797!GO:0045892;negative regulation of transcription, DNA-dependent;0.000413097978236354!GO:0006260;DNA replication;0.000416432457456859!GO:0004576;oligosaccharyl transferase activity;0.000416432457456859!GO:0035257;nuclear hormone receptor binding;0.000426972989958627!GO:0046930;pore complex;0.000448594400378649!GO:0016044;membrane organization and biogenesis;0.000490100226165665!GO:0031418;L-ascorbic acid binding;0.000490100226165665!GO:0005791;rough endoplasmic reticulum;0.000505300584490914!GO:0030663;COPI coated vesicle membrane;0.000561449050100161!GO:0030126;COPI vesicle coat;0.000561449050100161!GO:0048468;cell development;0.0005615545629791!GO:0006403;RNA localization;0.000566524406381704!GO:0065007;biological regulation;0.000583188735293796!GO:0004579;dolichyl-diphosphooligosaccharide-protein glycotransferase activity;0.000589142298212036!GO:0031543;peptidyl-proline dioxygenase activity;0.00062824771816686!GO:0050657;nucleic acid transport;0.000632932017385757!GO:0051236;establishment of RNA localization;0.000632932017385757!GO:0050658;RNA transport;0.000632932017385757!GO:0005048;signal sequence binding;0.000789591873828599!GO:0048518;positive regulation of biological process;0.000800798526745597!GO:0006891;intra-Golgi vesicle-mediated transport;0.000811900653313043!GO:0006334;nucleosome assembly;0.000826207326654977!GO:0006612;protein targeting to membrane;0.000853199282882043!GO:0005885;Arp2/3 protein complex;0.000861106621502677!GO:0031497;chromatin assembly;0.000925533135218524!GO:0043021;ribonucleoprotein binding;0.000989003142629436!GO:0030137;COPI-coated vesicle;0.00103081946273758!GO:0051920;peroxiredoxin activity;0.00109747879897856!GO:0030934;anchoring collagen;0.00110052048054771!GO:0045893;positive regulation of transcription, DNA-dependent;0.00117221634356757!GO:0005975;carbohydrate metabolic process;0.00119177270727228!GO:0045935;positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process;0.00119180154433482!GO:0033178;proton-transporting two-sector ATPase complex, catalytic domain;0.00119180154433482!GO:0051101;regulation of DNA binding;0.00119929814755359!GO:0019222;regulation of metabolic process;0.00120727257982681!GO:0019798;procollagen-proline dioxygenase activity;0.00125606270906357!GO:0046474;glycerophospholipid biosynthetic process;0.0012767742090759!GO:0030658;transport vesicle membrane;0.00128331340465107!GO:0043284;biopolymer biosynthetic process;0.0013814634936264!GO:0030199;collagen fibril organization;0.00140501775670952!GO:0045261;proton-transporting ATP synthase complex, catalytic core F(1);0.00141290578834656!GO:0019318;hexose metabolic process;0.00141362002857256!GO:0045941;positive regulation of transcription;0.00141577145907222!GO:0016779;nucleotidyltransferase activity;0.0014264178339659!GO:0006950;response to stress;0.00144925667743555!GO:0003724;RNA helicase activity;0.00146418017149192!GO:0030132;clathrin coat of coated pit;0.00147618940758927!GO:0018196;peptidyl-asparagine modification;0.00153084974615067!GO:0018279;protein amino acid N-linked glycosylation via asparagine;0.00153084974615067!GO:0043623;cellular protein complex assembly;0.00161878721221048!GO:0007050;cell cycle arrest;0.00170187907083984!GO:0005694;chromosome;0.0017350613143428!GO:0043681;protein import into mitochondrion;0.00178991540635979!GO:0008092;cytoskeletal protein binding;0.00179580785968254!GO:0005996;monosaccharide metabolic process;0.00217745428086662!GO:0016679;oxidoreductase activity, acting on diphenols and related substances as donors;0.00227797183342178!GO:0016681;oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor;0.00227797183342178!GO:0008121;ubiquinol-cytochrome-c reductase activity;0.00227797183342178!GO:0030308;negative regulation of cell growth;0.00247273908885327!GO:0016787;hydrolase activity;0.00250366608486234!GO:0030530;heterogeneous nuclear ribonucleoprotein complex;0.00251222338259908!GO:0030134;ER to Golgi transport vesicle;0.00253252070153934!GO:0005753;mitochondrial proton-transporting ATP synthase complex;0.00263021239213547!GO:0045792;negative regulation of cell size;0.00263854990979815!GO:0008283;cell proliferation;0.00271317391113102!GO:0006979;response to oxidative stress;0.00271317391113102!GO:0000314;organellar small ribosomal subunit;0.00273189101602149!GO:0005763;mitochondrial small ribosomal subunit;0.00273189101602149!GO:0008154;actin polymerization and/or depolymerization;0.00281692685992429!GO:0006414;translational elongation;0.00310552556225859!GO:0030127;COPII vesicle coat;0.00314519662817225!GO:0012507;ER to Golgi transport vesicle membrane;0.00314519662817225!GO:0051329;interphase of mitotic cell cycle;0.00314558925725494!GO:0044427;chromosomal part;0.00377613767871238!GO:0030660;Golgi-associated vesicle membrane;0.00404660308982613!GO:0048471;perinuclear region of cytoplasm;0.00405997382406565!GO:0005838;proteasome regulatory particle (sensu Eukaryota);0.00441651386929119!GO:0005852;eukaryotic translation initiation factor 3 complex;0.00462031352447734!GO:0009966;regulation of signal transduction;0.00471358090756409!GO:0046489;phosphoinositide biosynthetic process;0.00473809596766808!GO:0042802;identical protein binding;0.00474176299317776!GO:0015931;nucleobase, nucleoside, nucleotide and nucleic acid transport;0.00474176299317776!GO:0051098;regulation of binding;0.00486285743914109!GO:0048500;signal recognition particle;0.00489969678644746!GO:0009967;positive regulation of signal transduction;0.00496058556762989!GO:0015630;microtubule cytoskeleton;0.00557685028497206!GO:0065009;regulation of a molecular function;0.00561095184778535!GO:0001726;ruffle;0.00570621937459377!GO:0051028;mRNA transport;0.00573722480797488!GO:0016862;intramolecular oxidoreductase activity, interconverting keto- and enol-groups;0.00586548732860611!GO:0030659;cytoplasmic vesicle membrane;0.00596814838087545!GO:0030027;lamellipodium;0.00603244500920376!GO:0003729;mRNA binding;0.00613764130379942!GO:0051325;interphase;0.00615546331808007!GO:0046467;membrane lipid biosynthetic process;0.00644664255715575!GO:0032507;maintenance of cellular protein localization;0.00655529615778878!GO:0033673;negative regulation of kinase activity;0.00676986714059019!GO:0006469;negative regulation of protein kinase activity;0.00676986714059019!GO:0007265;Ras protein signal transduction;0.00681647530350012!GO:0042625;ATPase activity, coupled to transmembrane movement of ions;0.00700863123568688!GO:0005520;insulin-like growth factor binding;0.00705795260138891!GO:0006383;transcription from RNA polymerase III promoter;0.00724359921001826!GO:0043488;regulation of mRNA stability;0.00724554312583358!GO:0043487;regulation of RNA stability;0.00724554312583358!GO:0030521;androgen receptor signaling pathway;0.00725120887346231!GO:0003899;DNA-directed RNA polymerase activity;0.00726374886861608!GO:0051493;regulation of cytoskeleton organization and biogenesis;0.00795219938076953!GO:0033043;regulation of organelle organization and biogenesis;0.00795219938076953!GO:0001666;response to hypoxia;0.00795339552772929!GO:0017166;vinculin binding;0.00802808149278871!GO:0008186;RNA-dependent ATPase activity;0.00821115837349936!GO:0005813;centrosome;0.00835155011783793!GO:0016772;transferase activity, transferring phosphorus-containing groups;0.00835155011783793!GO:0030118;clathrin coat;0.00844200747553486!GO:0009165;nucleotide biosynthetic process;0.00883971479161859!GO:0035258;steroid hormone receptor binding;0.00912147376628425!GO:0045926;negative regulation of growth;0.00915245276168791!GO:0051348;negative regulation of transferase activity;0.00915245276168791!GO:0005869;dynactin complex;0.00916918902861208!GO:0001501;skeletal development;0.00922528832042829!GO:0006614;SRP-dependent cotranslational protein targeting to membrane;0.00931257444740648!GO:0045047;protein targeting to ER;0.00931257444740648!GO:0003746;translation elongation factor activity;0.0102176127902289!GO:0016765;transferase activity, transferring alkyl or aryl (other than methyl) groups;0.0102635288725387!GO:0007179;transforming growth factor beta receptor signaling pathway;0.010301788141148!GO:0048487;beta-tubulin binding;0.0103377167085957!GO:0007033;vacuole organization and biogenesis;0.0105782082230857!GO:0016281;eukaryotic translation initiation factor 4F complex;0.0114581533890801!GO:0031072;heat shock protein binding;0.0115229157280549!GO:0051168;nuclear export;0.0116432000414697!GO:0006402;mRNA catabolic process;0.0119323727799016!GO:0051252;regulation of RNA metabolic process;0.0119796845832608!GO:0008064;regulation of actin polymerization and/or depolymerization;0.0120283046627276!GO:0006626;protein targeting to mitochondrion;0.0120283046627276!GO:0006897;endocytosis;0.0120824144948059!GO:0010324;membrane invagination;0.0120824144948059!GO:0000307;cyclin-dependent protein kinase holoenzyme complex;0.0120824144948059!GO:0016197;endosome transport;0.0120978234481105!GO:0016676;oxidoreductase activity, acting on heme group of donors, oxygen as acceptor;0.0121201104405737!GO:0015002;heme-copper terminal oxidase activity;0.0121201104405737!GO:0016675;oxidoreductase activity, acting on heme group of donors;0.0121201104405737!GO:0004129;cytochrome-c oxidase activity;0.0121201104405737!GO:0030041;actin filament polymerization;0.0121949456831886!GO:0051235;maintenance of localization;0.0123708676677805!GO:0007006;mitochondrial membrane organization and biogenesis;0.0124081818651312!GO:0030176;integral to endoplasmic reticulum membrane;0.0126280586046411!GO:0005586;collagen type III;0.0126280586046411!GO:0048154;S100 beta binding;0.0126861630153519!GO:0043433;negative regulation of transcription factor activity;0.0127199596701468!GO:0006839;mitochondrial transport;0.0127199596701468!GO:0006007;glucose catabolic process;0.0128133201464632!GO:0006740;NADPH regeneration;0.0128780286393643!GO:0006098;pentose-phosphate shunt;0.0128780286393643!GO:0051128;regulation of cellular component organization and biogenesis;0.012896491546905!GO:0045936;negative regulation of phosphate metabolic process;0.0139209088620282!GO:0007040;lysosome organization and biogenesis;0.0139238937205965!GO:0005815;microtubule organizing center;0.0140195852589571!GO:0006890;retrograde vesicle-mediated transport, Golgi to ER;0.0142080104948777!GO:0007178;transmembrane receptor protein serine/threonine kinase signaling pathway;0.0146631836350174!GO:0051651;maintenance of cellular localization;0.0146934287993591!GO:0030865;cortical cytoskeleton organization and biogenesis;0.014735861335804!GO:0044433;cytoplasmic vesicle part;0.0147507196805259!GO:0019752;carboxylic acid metabolic process;0.0147507196805259!GO:0045185;maintenance of protein localization;0.0147546524722827!GO:0008312;7S RNA binding;0.0147594563543304!GO:0006022;aminoglycan metabolic process;0.0149606995751871!GO:0003690;double-stranded DNA binding;0.0150167690307933!GO:0006650;glycerophospholipid metabolic process;0.0150807483267195!GO:0000122;negative regulation of transcription from RNA polymerase II promoter;0.0154680902786302!GO:0051540;metal cluster binding;0.0156162455337482!GO:0051536;iron-sulfur cluster binding;0.0156162455337482!GO:0030518;steroid hormone receptor signaling pathway;0.0157521532680415!GO:0005786;signal recognition particle, endoplasmic reticulum targeting;0.0161119202168105!GO:0006595;polyamine metabolic process;0.0162053570055587!GO:0006082;organic acid metabolic process;0.0167639077233941!GO:0048144;fibroblast proliferation;0.016783622128434!GO:0048145;regulation of fibroblast proliferation;0.016783622128434!GO:0015405;P-P-bond-hydrolysis-driven transmembrane transporter activity;0.0172862578732205!GO:0015399;primary active transmembrane transporter activity;0.0172862578732205!GO:0030832;regulation of actin filament length;0.0173121556518965!GO:0045263;proton-transporting ATP synthase complex, coupling factor F(o);0.0173783227279287!GO:0033177;proton-transporting two-sector ATPase complex, proton-transporting domain;0.0173783227279287!GO:0022890;inorganic cation transmembrane transporter activity;0.0173805569961222!GO:0005774;vacuolar membrane;0.0178321213535652!GO:0046483;heterocycle metabolic process;0.0180488311439423!GO:0005578;proteinaceous extracellular matrix;0.0183265922943757!GO:0007010;cytoskeleton organization and biogenesis;0.0183963993188723!GO:0035035;histone acetyltransferase binding;0.0187015127505559!GO:0032535;regulation of cellular component size;0.0187360986724067!GO:0004004;ATP-dependent RNA helicase activity;0.0187954221364535!GO:0006693;prostaglandin metabolic process;0.0191388041215791!GO:0006692;prostanoid metabolic process;0.0191388041215791!GO:0008286;insulin receptor signaling pathway;0.0192924265143669!GO:0005684;U2-dependent spliceosome;0.0194357534114742!GO:0030125;clathrin vesicle coat;0.0195429298009446!GO:0030665;clathrin coated vesicle membrane;0.0195429298009446!GO:0030880;RNA polymerase complex;0.0195429298009446!GO:0007030;Golgi organization and biogenesis;0.0198297579541603!GO:0003756;protein disulfide isomerase activity;0.0199908020222221!GO:0016864;intramolecular oxidoreductase activity, transposing S-S bonds;0.0199908020222221!GO:0032956;regulation of actin cytoskeleton organization and biogenesis;0.0200738714181479!GO:0045045;secretory pathway;0.020502992088444!GO:0043022;ribosome binding;0.0208419410363388!GO:0031529;ruffle organization and biogenesis;0.0208783365723448!GO:0051059;NF-kappaB binding;0.0209287165427909!GO:0001516;prostaglandin biosynthetic process;0.0213661882223891!GO:0046457;prostanoid biosynthetic process;0.0213661882223891!GO:0046822;regulation of nucleocytoplasmic transport;0.0223813109871156!GO:0000082;G1/S transition of mitotic cell cycle;0.0225735314370345!GO:0017015;regulation of transforming growth factor beta receptor signaling pathway;0.0226797210383894!GO:0006818;hydrogen transport;0.0230680224288588!GO:0007034;vacuolar transport;0.0235832750752293!GO:0022403;cell cycle phase;0.0235832750752293!GO:0030833;regulation of actin filament polymerization;0.0240726261714187!GO:0006506;GPI anchor biosynthetic process;0.0242198900288259!GO:0030203;glycosaminoglycan metabolic process;0.0242429209412773!GO:0006352;transcription initiation;0.0242429209412773!GO:0006354;RNA elongation;0.0244264583497319!GO:0031902;late endosome membrane;0.0248922658338779!GO:0043065;positive regulation of apoptosis;0.0256470871328064!GO:0009225;nucleotide-sugar metabolic process;0.0262366343150206!GO:0050811;GABA receptor binding;0.026352472494575!GO:0005584;collagen type I;0.0263803523103439!GO:0006401;RNA catabolic process;0.026411747230778!GO:0008147;structural constituent of bone;0.0265399538304262!GO:0015992;proton transport;0.0269818701772862!GO:0008139;nuclear localization sequence binding;0.0269922366651501!GO:0006607;NLS-bearing substrate import into nucleus;0.0278782417842835!GO:0006892;post-Golgi vesicle-mediated transport;0.0280025795530345!GO:0007041;lysosomal transport;0.0282650631411479!GO:0006790;sulfur metabolic process;0.0282982636949758!GO:0048146;positive regulation of fibroblast proliferation;0.0286705622120177!GO:0031901;early endosome membrane;0.0293260258468873!GO:0043068;positive regulation of programmed cell death;0.030292327887932!GO:0006118;electron transport;0.0304294668197115!GO:0016408;C-acyltransferase activity;0.0304294668197115!GO:0012506;vesicle membrane;0.0308766609117479!GO:0051045;negative regulation of membrane protein ectodomain proteolysis;0.0308803786046267!GO:0051043;regulation of membrane protein ectodomain proteolysis;0.0308803786046267!GO:0016860;intramolecular oxidoreductase activity;0.031187644005564!GO:0006509;membrane protein ectodomain proteolysis;0.0313217723971755!GO:0033619;membrane protein proteolysis;0.0313217723971755!GO:0007160;cell-matrix adhesion;0.032224047540783!GO:0016780;phosphotransferase activity, for other substituted phosphate groups;0.032224047540783!GO:0016721;oxidoreductase activity, acting on superoxide radicals as acceptor;0.0324875096695316!GO:0004784;superoxide dismutase activity;0.0324875096695316!GO:0042326;negative regulation of phosphorylation;0.0326360816194214!GO:0005862;muscle thin filament tropomyosin;0.0327579173049047!GO:0004860;protein kinase inhibitor activity;0.0327849566829235!GO:0030145;manganese ion binding;0.0331190044936183!GO:0006611;protein export from nucleus;0.0332445482119738!GO:0004656;procollagen-proline 4-dioxygenase activity;0.0333609851859807!GO:0031545;peptidyl-proline 4-dioxygenase activity;0.0333609851859807!GO:0000786;nucleosome;0.0333609851859807!GO:0006505;GPI anchor metabolic process;0.0333609851859807!GO:0031589;cell-substrate adhesion;0.0334841525089622!GO:0005593;FACIT collagen;0.0336106559812553!GO:0002474;antigen processing and presentation of peptide antigen via MHC class I;0.0336106559812553!GO:0051539;4 iron, 4 sulfur cluster binding;0.0336106559812553!GO:0005585;collagen type II;0.0336106559812553!GO:0045639;positive regulation of myeloid cell differentiation;0.0340231921319659!GO:0030433;ER-associated protein catabolic process;0.0341785445653308!GO:0006515;misfolded or incompletely synthesized protein catabolic process;0.0341785445653308!GO:0008632;apoptotic program;0.0347940535653861!GO:0055029;nuclear DNA-directed RNA polymerase complex;0.035005100905757!GO:0000428;DNA-directed RNA polymerase complex;0.035005100905757!GO:0005665;DNA-directed RNA polymerase II, core complex;0.0350697990213278!GO:0008383;manganese superoxide dismutase activity;0.035593916688232!GO:0001315;age-dependent response to reactive oxygen species;0.035593916688232!GO:0003702;RNA polymerase II transcription factor activity;0.0361078308114594!GO:0008610;lipid biosynthetic process;0.0362794736023689!GO:0031625;ubiquitin protein ligase binding;0.03658309722708!GO:0006497;protein amino acid lipidation;0.0368103864530746!GO:0051087;chaperone binding;0.0371177267496271!GO:0044437;vacuolar part;0.0374977518854075!GO:0030866;cortical actin cytoskeleton organization and biogenesis;0.0376146179052002!GO:0022408;negative regulation of cell-cell adhesion;0.0376197043757395!GO:0008180;signalosome;0.0378558975594445!GO:0022415;viral reproductive process;0.0380695396152306!GO:0007067;mitosis;0.0381419930619408!GO:0044275;cellular carbohydrate catabolic process;0.0384009007728033!GO:0008475;procollagen-lysine 5-dioxygenase activity;0.0384009007728033!GO:0004177;aminopeptidase activity;0.0396729293539109!GO:0000049;tRNA binding;0.0397994407686814!GO:0000087;M phase of mitotic cell cycle;0.0401454744062536!GO:0050681;androgen receptor binding;0.0405919271437144!GO:0003711;transcription elongation regulator activity;0.0414387683431364!GO:0051287;NAD binding;0.041739171844531!GO:0006417;regulation of translation;0.0418125191572907!GO:0000902;cell morphogenesis;0.0419643306084603!GO:0032989;cellular structure morphogenesis;0.0419643306084603!GO:0031323;regulation of cellular metabolic process;0.0424895855715209!GO:0006778;porphyrin metabolic process;0.0434610302790358!GO:0033013;tetrapyrrole metabolic process;0.0434610302790358!GO:0006984;ER-nuclear signaling pathway;0.0434610302790358!GO:0009112;nucleobase metabolic process;0.0436466716334813!GO:0004228;gelatinase A activity;0.0437061258372838!GO:0001955;blood vessel maturation;0.0437061258372838!GO:0006643;membrane lipid metabolic process;0.0447976820750714!GO:0050662;coenzyme binding;0.0448232727767858!GO:0045944;positive regulation of transcription from RNA polymerase II promoter;0.0448232727767858!GO:0008484;sulfuric ester hydrolase activity;0.0448232727767858!GO:0016251;general RNA polymerase II transcription factor activity;0.0456634365200444!GO:0004248;stromelysin 1 activity;0.0456634365200444!GO:0030384;phosphoinositide metabolic process;0.04621258193548!GO:0046870;cadmium ion binding;0.0471292716821926!GO:0030522;intracellular receptor-mediated signaling pathway;0.0475743703090761!GO:0032981;mitochondrial respiratory chain complex I assembly;0.048012951437898!GO:0010257;NADH dehydrogenase complex assembly;0.048012951437898!GO:0033108;mitochondrial respiratory chain complex assembly;0.048012951437898!GO:0006807;nitrogen compound metabolic process;0.0482461121771939!GO:0046365;monosaccharide catabolic process;0.0482461121771939!GO:0002763;positive regulation of myeloid leukocyte differentiation;0.0483717364132288!GO:0001953;negative regulation of cell-matrix adhesion;0.0485104912349004!GO:0000118;histone deacetylase complex;0.0488450854313112!GO:0008047;enzyme activator activity;0.048922475434155!GO:0033239;negative regulation of amine metabolic process;0.0490341271144698!GO:0045763;negative regulation of amino acid metabolic process;0.0490341271144698!GO:0001933;negative regulation of protein amino acid phosphorylation;0.0490341271144698!GO:0030569;chymotrypsin inhibitor activity;0.0491756880698982!GO:0040029;regulation of gene expression, epigenetic;0.0496130371554087!GO:0030119;AP-type membrane coat adaptor complex;0.0496478179336958 | |||
|sample_id=11411 | |sample_id=11411 | ||
|sample_note= | |sample_note= |
Revision as of 17:40, 25 June 2012
Name: | Chondrocyte - re diff, donor3 |
---|---|
Species: | Human (Homo sapiens) |
Library ID: | {{{library_id}}} |
Sample type: | {{{sample_category}}} |
Genomic View: | UCSC |
CAGEd-oPOSSUM: | link |
Additional information | ||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sample information
RNA information
|
Download raw sequence, BAM & CTSS | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Relative expression to median (log10)
Transcription factors with enriched expression in this sampleRanked list of transcription factor promoter expression in this sample relative to the median expression in the FANTOM5 collection is shown. Value is log10 transformed.
Co-expression clusters with enriched expression in this sampleRanked list of co-expression cluster expression in this sample relative to the median expression in the FANTOM5 collection is shown. Value is log10 transformed. <br>Analyst:NA <br><br>link to dataset.<br>data
Repeat families with enriched expression in this sample<b>Summary:</b>Ranked list of repeat family expression in this sample relative tothe median expression in the FANTOM5 collection is shown. Value is log10transformed.<br><b>Analyst:</b>NA<br><br>link to dataset.<br>data
no result for this sample
TFBS(DNA)motifs over-represented in proximal region of promoters active in this sample
JASPAR motifs<b>Summary:</b>Association of JASPAR motif to the promoter expression in thissample. Pearson's correlation between the number of TFBSs estimated byusing the position-weight matrix for each promoter and its expression isexpressed as Z-score by taking the ones based on random position-weightmatrix, and the tail probability of the normal distribution correspondingto the Z-score is taken as the resulting P-value. Lower P-value indicatesmore (non-random) association of the motif to promoter expression<br><b>Analyst:</b> Michiel de Hoon <br><br><br>link to dataset.<br>data
library id: CNhs12021
FANTOM5 phase1 novel unique motifs<b>Summary:</b>Association of the 169 novel and unique motifs discovered in FANTOM5 phase1 in this sample. Among the de-novo motifs discovered by DMF, HOMER,ChIPMunk, and ScanAll, only novel motifs are selected after comparison with known motif sets, and their clustering based on MACRO-APE resulted in169 novel and unique motifs. Their association to the promoter expression is evaluated in the same way to the JASPAR motif above<br><b>Analyst:</b> Michiel de Hoon <br><br><br>link to dataset.<br>data
library id: CNhs12021
Novel motif | Logo | P-value |
---|---|---|
1 | 1 | 0.253 |
10 | 10 | 0.524 |
100 | 100 | 0.544 |
101 | 101 | 0.121 |
102 | 102 | 0.833 |
103 | 103 | 0.759 |
104 | 104 | 0.81 |
105 | 105 | 0.00122 |
106 | 106 | 0.245 |
107 | 107 | 0.0455 |
108 | 108 | 0.352 |
109 | 109 | 0.711 |
11 | 11 | 0.622 |
110 | 110 | 0.466 |
111 | 111 | 0.881 |
112 | 112 | 0.884 |
113 | 113 | 0.122 |
114 | 114 | 0.701 |
115 | 115 | 0.0422 |
116 | 116 | 0.0326 |
117 | 117 | 0.321 |
118 | 118 | 0.969 |
119 | 119 | 0.353 |
12 | 12 | 0.423 |
120 | 120 | 0.776 |
121 | 121 | 0.223 |
122 | 122 | 0.0537 |
123 | 123 | 0.244 |
124 | 124 | 0.0381 |
125 | 125 | 0.758 |
126 | 126 | 0.329 |
127 | 127 | 0.699 |
128 | 128 | 0.212 |
129 | 129 | 0.298 |
13 | 13 | 0.714 |
130 | 130 | 0.464 |
131 | 131 | 0.749 |
132 | 132 | 0.122 |
133 | 133 | 0.432 |
134 | 134 | 0.878 |
135 | 135 | 0.614 |
136 | 136 | 0.773 |
137 | 137 | 0.448 |
138 | 138 | 0.739 |
139 | 139 | 0.306 |
14 | 14 | 0.364 |
140 | 140 | 0.402 |
141 | 141 | 0.408 |
142 | 142 | 0.132 |
143 | 143 | 0.57 |
144 | 144 | 0.139 |
145 | 145 | 0.428 |
146 | 146 | 0.419 |
147 | 147 | 0.617 |
148 | 148 | 0.249 |
149 | 149 | 0.00887 |
15 | 15 | 0.262 |
150 | 150 | 0.3 |
151 | 151 | 0.752 |
152 | 152 | 0.0366 |
153 | 153 | 0.696 |
154 | 154 | 0.897 |
155 | 155 | 0.892 |
156 | 156 | 0.879 |
157 | 157 | 0.311 |
158 | 158 | 0.00743 |
159 | 159 | 0.439 |
16 | 16 | 0.0968 |
160 | 160 | 0.658 |
161 | 161 | 0.658 |
162 | 162 | 0.814 |
163 | 163 | 0.911 |
164 | 164 | 0.089 |
165 | 165 | 0.815 |
166 | 166 | 0.0161 |
167 | 167 | 0.749 |
168 | 168 | 0.325 |
169 | 169 | 0.103 |
17 | 17 | 0.922 |
18 | 18 | 0.751 |
19 | 19 | 0.0169 |
2 | 2 | 0.198 |
20 | 20 | 0.795 |
21 | 21 | 0.801 |
22 | 22 | 0.237 |
23 | 23 | 0.314 |
24 | 24 | 0.071 |
25 | 25 | 0.155 |
26 | 26 | 0.599 |
27 | 27 | 0.552 |
28 | 28 | 0.142 |
29 | 29 | 0.271 |
3 | 3 | 0.539 |
30 | 30 | 0.561 |
31 | 31 | 0.593 |
32 | 32 | 3.68898e-12 |
33 | 33 | 0.44 |
34 | 34 | 0.467 |
35 | 35 | 0.427 |
36 | 36 | 0.0486 |
37 | 37 | 0.701 |
38 | 38 | 0.632 |
39 | 39 | 0.604 |
4 | 4 | 0.852 |
40 | 40 | 0.356 |
41 | 41 | 0.166 |
42 | 42 | 0.287 |
43 | 43 | 0.865 |
44 | 44 | 0.7 |
45 | 45 | 0.463 |
46 | 46 | 0.873 |
47 | 47 | 0.038 |
48 | 48 | 0.394 |
49 | 49 | 0.47 |
5 | 5 | 0.906 |
50 | 50 | 0.522 |
51 | 51 | 0.403 |
52 | 52 | 0.538 |
53 | 53 | 0.134 |
54 | 54 | 0.483 |
55 | 55 | 0.905 |
56 | 56 | 0.965 |
57 | 57 | 0.299 |
58 | 58 | 0.214 |
59 | 59 | 0.0213 |
6 | 6 | 0.213 |
60 | 60 | 0.447 |
61 | 61 | 0.59 |
62 | 62 | 0.374 |
63 | 63 | 0.719 |
64 | 64 | 0.329 |
65 | 65 | 0.458 |
66 | 66 | 0.0374 |
67 | 67 | 0.79 |
68 | 68 | 0.683 |
69 | 69 | 0.387 |
7 | 7 | 0.416 |
70 | 70 | 0.465 |
71 | 71 | 0.356 |
72 | 72 | 0.33 |
73 | 73 | 0.0141 |
74 | 74 | 0.453 |
75 | 75 | 0.633 |
76 | 76 | 0.355 |
77 | 77 | 0.00305 |
78 | 78 | 0.249 |
79 | 79 | 0.00263 |
8 | 8 | 0.756 |
80 | 80 | 0.159 |
81 | 81 | 0.762 |
82 | 82 | 0.705 |
83 | 83 | 0.0478 |
84 | 84 | 0.892 |
85 | 85 | 0.133 |
86 | 86 | 0.647 |
87 | 87 | 0.386 |
88 | 88 | 0.361 |
89 | 89 | 0.0729 |
9 | 9 | 0.788 |
90 | 90 | 0.133 |
91 | 91 | 0.886 |
92 | 92 | 0.581 |
93 | 93 | 0.682 |
94 | 94 | 0.31 |
95 | 95 | 0.754 |
96 | 96 | 0.858 |
97 | 97 | 0.483 |
98 | 98 | 0.989 |
99 | 99 | 0.301 |
de novo motifs identified by HOMER in promoters active in this sample<b>Summary:</b>The result of HOMER in this sample is shown.<br><b>Analyst:</b>NA <br>
library id: CNhs12021
FANTOM5 (FF) ontology
Direct parent terms
is_a relathionship
EFO:0002091 biological replicate
FF:0000002 in vivo cell sample
FF:0000210 human sample
FF:0000245 human chondrocyte re-differentiated sample
Ancestor terms (non development)<b>Summary:</b>Connected ontology terms with is_a, part_of or located_in relationship <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source data<br>data
CL: Cell type
0000000 (cell), 0000000 (cell)
0000003 (native cell)
0000055 (non-terminally differentiated cell)
0000723 (somatic stem cell)
0000048 (multi fate stem cell)
0000548 (animal cell)
0000034 (stem cell)
0000151 (secretory cell)
0002320 (connective tissue cell)
0002371 (somatic cell)
0000219 (motile cell)
0000499 (stromal cell)
0000153 (GAG secreting cell)
0000667 (collagen secreting cell)
0000327 (extracellular matrix secreting cell)
0000447 (carbohydrate secreting cell)
0000134 (mesenchymal cell)
0000255 (eukaryotic cell)
0000058 (chondroblast)
0000138 (chondrocyte)
UBERON: Anatomy
0002384 (connective tissue)
0000479 (tissue)
0000061 (anatomical structure)
0000465 (material anatomical entity)
0001062 (anatomical entity)
FF: FANTOM5
NA
Ancestor terms (development)<b>Summary:</b>Connected ontology terms with develops_from, derives_from or preceded_by relationship <br><b>Analyst:</b> Hideya Kawaji <br><br>link to source data<br>data
NA